Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAtla (BCAB) EBT (2020 - 2025)

BioAtla (BCAB) has 6 years of EBT data on record, last reported at -$13.7 million in Q3 2025.

  • For Q3 2025, EBT fell 29.1% year-over-year to -$13.7 million; the TTM value through Sep 2025 reached -$65.0 million, up 20.55%, while the annual FY2024 figure was -$70.6 million, 42.8% up from the prior year.
  • EBT reached -$13.7 million in Q3 2025 per BCAB's latest filing, up from -$18.4 million in the prior quarter.
  • Across five years, EBT topped out at -$10.6 million in Q3 2024 and bottomed at -$35.7 million in Q2 2023.
  • Average EBT over 5 years is -$23.5 million, with a median of -$23.6 million recorded in 2021.
  • Peak YoY movement for EBT: crashed 1593.93% in 2021, then soared 68.22% in 2024.
  • A 5-year view of EBT shows it stood at -$23.4 million in 2021, then dropped by 17.62% to -$27.5 million in 2022, then increased by 2.24% to -$26.9 million in 2023, then surged by 41.67% to -$15.7 million in 2024, then increased by 12.96% to -$13.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBT were -$13.7 million in Q3 2025, -$18.4 million in Q2 2025, and -$17.2 million in Q1 2025.